SEARCH

SEARCH BY CITATION

References

  • 1
    Food and Drug Administration Nonprescription Drugs Advisory Committee. Briefing Information. Section III: NSAID/Aspirin Reviews: Aspirin — GI Bleed, NSAID — GI Bleed September 19, 2002. In: http://www.fda.gov/ohrms/dockets/ac/02/briefing/3882b1.htm; accessed January 28, 2003.
  • 2
    Edwards JE, Oldman A, Smith L, et al. Single dose oral aspirin for acute pain. Cochrane Database Syst Rev 2000; 2: CD002067.
  • 3
    Henry D, Lim LL, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. Br Med J 1996; 312: 15636.
  • 4
    Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996; 348: 14136.
  • 5
    Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994; 330(18): 128794.
  • 6
    Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995; 310: 82730.
  • 7
    Roderick PJ, Wilkes HC, Meade TW. The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol 1993; 35(3): 21926.
  • 8
    Hoftiezer JW, O'Laughlin JC, Ivey KJ. Effects of 24 hours of aspirin, Bufferin, paracetamol and placebo on normal human gastroduodenal mucosa. Gut 1982; 23(8): 6927.
  • 9
    Graham DY, Smith JL. Aspirin and the stomach. Ann Intern Med 1986; 104(3): 3908.
  • 10
    Hawthorne AB, Mahida YR, Cole AT, Hawkey CJ. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis. Br J Clin Pharmacol 1991; 32(1): 7783.
  • 11
    Stern AI, Ward F. Buffered aspirin is less damaging to the human gastric mucosa than regular aspirin. Gastroenterology 1985; 88(5): 1600.
  • 12
    Goeke B, Arnold R. Buffering protects against aspirin-induced gastric-mucosal injury. Med Klinik 1989; 84(10): 4748.
  • 13
    Hawkey CJ. Review article: aspirin and gastrointestinal bleeding. Aliment Pharmacol Ther 1994; 8(2): 1416.
  • 14
    McAlindon ME, Muller AF, Filipowicz B, Hawkey CJ. Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers. Gut 1996; 38(4): 51824.
  • 15
    Simon B, Dammann HG, Mueller P. Acute acetylsalicylic acid damage to the human gastric mucosa: an endoscopic study with antacids, H2 blockers, prostaglandins and omeprazole. Z Rheumatol 1986; 45(4): 182.
  • 16
    Tolman KG, Detweiler MK, Harrison CA, et al. Effect of rioprostil on aspirin-induced gastrointestinal mucosal changes in normal volunteers. J Clin Pharmacol 1988; 28(1): 7680.
  • 17
    Lanza FL, Kochman RL, Geis GS, Rack EM, Deysach LG. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits. Am J Gastroenterol 1991; 86(12): 17438.
  • 18
    Stern AI, Hogan DL, Kahn LH, Isenberg JI. Acetaminophen protects the human stomach from the damaging effects of aspirin and ethanol. Gastroenterology 1983; 84(5): 1324.
  • 19
    Graham DY, Smith JL. Effects of aspirin and an aspirin–acetaminophen combination on the gastric mucosa in normal subjects. A double-blind endoscopic study. Gastroenterology 1985; 88(6): 19225.
  • 20
    Lanza FL. A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects. Dig Dis Sci 1986; 31(2 Suppl.): 131S136S.
  • 21
    Hawkey CJ, Simpson G, Somerville KW. Reduction by enprostil of aspirin-induced blood loss from human gastric mucosa. Am J Med 1986; 81(2A): 503.
  • 22
    Hunt JN. A procedure for measuring gastric bleeding caused by drugs. Dig Dis Sci 1979; 24(7): 5258.
  • 23
    Pohle T, Brzozowski T, Becker JC, et al. Role of reactive oxygen metabolites in aspirin-induced gastric damage in humans: gastroprotection by vitamin C. Aliment Pharmacol Ther 2001; 15(5): 67787.
  • 24
    Motola G, Russo F, Mazzeo F, et al. Over-the-counter oral nonsteroidal anti-inflammatory drugs: a pharmacoepidemiologic study in southern Italy. Adv Ther 2001; 18(5): 21622.
  • 25
    Steiner TJ, Lange R, Voelker M. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 2003; 23(1): 5966.